关注
Alexandra Gabriela Ferreira
Alexandra Gabriela Ferreira
未知所在单位机构
在 med.lu.se 的电子邮件经过验证
标题
引用次数
引用次数
年份
Direct reprogramming of fibroblasts into antigen-presenting dendritic cells
FF Rosa, CF Pires, I Kurochkin, AG Ferreira, AM Gomes, LG Palma, ...
Science immunology 3 (30), eaau4292, 2018
982018
Cell fate reprogramming in the era of cancer immunotherapy
O Zimmermannova, I Caiado, AG Ferreira, CF Pereira
Frontiers in immunology 12, 714822, 2021
422021
Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells
FF Rosa, CF Pires, I Kurochkin, E Halitzki, T Zahan, N Arh, ...
Science immunology 7 (69), eabg5539, 2022
342022
Restoring tumor immunogenicity with dendritic cell reprogramming
O Zimmermannova, AG Ferreira, E Ascic, M Velasco Santiago, ...
Science immunology 8 (85), eadd4817, 2023
162023
GATA2 mitotic bookmarking is required for definitive haematopoiesis
R Silvério-Alves, I Kurochkin, A Rydström, C Vazquez Echegaray, ...
Nature Communications 14 (1), 4645, 2023
52023
Reprogramming Cancer Cells to Antigen-presenting Cells
AG Ferreira, O Zimmermannova, I Kurochkin, E Ascic, F Åkerström, ...
Bio-protocol 13 (22), 2023
22023
Orchestrating an immune response to cancer with cellular reprogramming
O Zimmermannova, AG Ferreira, CF Pereira
Genes & Immunity 25 (1), 95-97, 2024
12024
Restoring antitumor immunity with dendritic cell reprogramming strategies. Reprogramming cancer cells to antigen-presenting cells.
AGB Ferreira
2023
Restoring antitumor immunity with dendritic cell reprogramming strategies. Reprogramming cancer cells to antigen-presenting cells.
AG Barros Ferreira
Lund University, Faculty of Medicine Doctoral Dissertation Series, 2023
2023
Abstract A40: Restoring tumor immunogenicity with dendritic cell reprogramming
AG Ferreira, O Zimmermannova, E Ascic, I Kurochkin, D Soto-Cabrera, ...
Cancer Immunology Research 10 (12_Supplement), A40-A40, 2022
2022
Direct Reprogramming of Mouse and Human Fibroblasts into Conventional Dendritic Cells Type 1
FF Rosa, CF Pires, I Kurochkin, AG Ferreira, O Schulz, CR e Sousa, ...
Molecular Immunology 150, 22, 2022
2022
Eliciting Anti-Tumor Immunity by Reprogramming Cancer Cells to Type 1 Conventional Dendritic Cells
E Ascic, AGB Ferreira, H Benonisson, I Kurochkin, IMN Caiado, ...
European Association for Cancer Research 2022-Congress: Innovative Cancer …, 2022
2022
Harnessing Dendritic Cell Reprogramming to Elucidate Mechanisms of Tumor Immunity
E Ascic, AGB Ferreira, H Benonisson, I Kurochkin, IMN Caiado, ...
Lund Stem Cell Center Retreat, 2022
2022
Reprogramming Human Cancer Cells into Antigen Presentation
O Zimmermannova, I Kurochkin, DS Cabrera, AE Tenreiro, H Benonisson, ...
Blood 138, 1709, 2021
2021
Single-cell RNA-seq informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells
FF Rosa, CF Pires, I Kurochkin, O Zimmermannova, AG Ferreira, ...
HUMAN GENE THERAPY 32 (19-20), A94-A94, 2021
2021
3063–RESTORING THE IMMUNOGENICITY OF CANCER CELLS WITH DENDRITIC CELL REPROGRAMMING
AG Ferreira, E Ascic, I Caiado, O Zimmermannova, I Kurochkin, F Rosa, ...
Experimental Hematology 100, S72, 2021
2021
Generating a personalized immunotherapy by reprogramming fibroblasts to regulatory T cells
AGB Ferreira
2017
系统目前无法执行此操作,请稍后再试。
文章 1–17